296 related articles for article (PubMed ID: 34087151)
1. The effect of non-AIDS-defining cancers on people living with HIV.
Chiao EY; Coghill A; Kizub D; Fink V; Ndlovu N; Mazul A; Sigel K
Lancet Oncol; 2021 Jun; 22(6):e240-e253. PubMed ID: 34087151
[TBL] [Abstract][Full Text] [Related]
2. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
3. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
4. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
5. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients living with HIV and cancer in Cali, Colombia.
Parra-Lara LG; Arango-Ibañez JP; Martínez-Arboleda JJ; Bravo JC; Zambrano ÁR; Collazos P; Andino F; Badillo A; Estrada S; Rosso F
Colomb Med (Cali); 2023; 54(3):e2015558. PubMed ID: 38098512
[TBL] [Abstract][Full Text] [Related]
7. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer in women living with HIV.
D'Andrea F; Ceccarelli M; Facciolà A; Nunnari G; Pellicanò GF; Venanzi Rullo E
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1158-1164. PubMed ID: 30779085
[TBL] [Abstract][Full Text] [Related]
10. Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials.
Bender Ignacio RA; Lin LL; Rajdev L; Chiao E
J Natl Compr Canc Netw; 2018 Aug; 16(8):1018-1026. PubMed ID: 30099376
[TBL] [Abstract][Full Text] [Related]
11. Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study.
Haas CB; Engels EA; Horner MJ; Freedman ND; Luo Q; Gershman S; Qiao B; Pfeiffer RM; Shiels MS
Lancet HIV; 2022 Oct; 9(10):e700-e708. PubMed ID: 36179753
[TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
13. Study of 172 Cases of AIDS Associated Cancers.
Phatak UA; Gosavi VS; Chitale PV
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062808
[TBL] [Abstract][Full Text] [Related]
14. Malignancies in HIV-Infected and AIDS Patients.
Ji Y; Lu H
Adv Exp Med Biol; 2017; 1018():167-179. PubMed ID: 29052137
[TBL] [Abstract][Full Text] [Related]
15. Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article.
Makuku R; Seyedmirzaei H; Tantuoyir MM; Rodríguez-Román E; Albahash A; Mohamed K; Moyo E; Ahmed AO; Razi S; Rezaei N
Int Immunopharmacol; 2022 Apr; 105():108580. PubMed ID: 35121225
[TBL] [Abstract][Full Text] [Related]
16. Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015.
Horner MJ; Shiels MS; Pfeiffer RM; Engels EA
Clin Infect Dis; 2021 May; 72(9):e224-e231. PubMed ID: 32710777
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
18. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
19. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
20. Cancer incidence in people living with HIV/AIDS in Israel, 1981-2010.
Zohar M; Micha B
AIDS Res Hum Retroviruses; 2015 Sep; 31(9):873-81. PubMed ID: 25941873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
